Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients - Ronzoni, M; Manzoni, M; Mariucci, S (Ann Oncol, 2010)
, et al.